PEAK6 Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,300
Closed -$427K 5019
2020
Q4
$427K Hold
21,300
﹤0.01% 3209
2020
Q3
$521K Hold
21,300
﹤0.01% 2818
2020
Q2
$506K Hold
21,300
﹤0.01% 2662
2020
Q1
$367K Sell
21,300
-27,600
-56% -$505K ﹤0.01% 2349
2019
Q4
$862K Sell
48,900
-39,100
-44% -$663K ﹤0.01% 1617
2019
Q3
$1.56M Buy
88,000
+24,300
+38% +$492K 0.01% 1440
2019
Q2
$1.36M Buy
63,700
+61,100
+2,350% +$1.28M 0.01% 1571
2019
Q1
$62K Buy
+2,600
New +$59.3K ﹤0.01% 3356

Other funds holding EXEL

PEAK6 Investments's EXEL Position: Q1 2021 in Review

PEAK6 Investments sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 905 shares — an estimated $18K sold.

PEAK6 Investments first reported a position in EXEL in Q2 2019 and held it in 7 quarters. The position peaked at $411K in Q3 2019. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • PEAK6 Investments reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • PEAK6 Investments sold 905 Exelixis shares in Q1 2021, an estimated $18K.
  • PEAK6 Investments first reported a position in Exelixis in Q2 2019 and held it in 7 quarters.
  • PEAK6 Investments's Exelixis position peaked at $411K in Q3 2019.
  • 347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on PEAK6 Investments's 13F filing for Q1 2021, filed 14 May 2021.